Healthcare services company Sotera Health (NASDAQ: SHC) will be reporting earnings this Thursday before market hours. Here’s what you need to know.
Sotera Health Company beat analysts’ revenue expectations last quarter, reporting revenues of $280 million, up 10% year on year. It was a strong quarter for the company, with an impressive beat of analysts’ organic revenue estimates and EPS in line with analysts’ estimates.
Is Sotera Health Company a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, the market is expecting Sotera Health Company’s revenue to grow 5.2% year on year, slowing from the 6.4% increase it recorded in the same quarter last year.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business will stay the course heading into earnings. Sotera Health Company has a history of exceeding Wall Street’s expectations.
Looking at Sotera Health Company’s peers in the research tools & consumables segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Avantor posted flat year-on-year revenue, beating analysts’ expectations by 4.9%, and Thermo Fisher reported revenues up 10.5%, topping estimates by 2.4%. Avantor traded up 11.6% following the results while Thermo Fisher was also up 7.9%.
Read our full analysis of Avantor’s results here and Thermo Fisher’s results here.
Investors in the research tools & consumables segment have had steady hands going into earnings, with share prices up 1.4% on average over the last month. Sotera Health Company is up 1.2% during the same time and is heading into earnings with an average analyst price target of $20.44 (compared to the current share price of $18.08).
ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.
AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.
